Skip to main content
. 2022 Dec 10;12:21393. doi: 10.1038/s41598-022-25739-5

Table 2.

Effect of test compounds on acetylcholine (Ach) induced relaxation in aortae.

Treatment groups Acetylcholine (Ach) induced relaxation in aortae
Aortae with perivascular adipose tissue (PVAT) Aortae without PVAT
Endothelium intact Endothelium intact
Abdominal aortae Thoracic aortae Abdominal aortae Thoracic aortae
Rmax pEC50 Rmax pEC50 Rmax pEC50 Rmax pEC50
Normal 104.8 ± 4.2 5.2 ± 0.1 105.2 ± 4.4 5.6 ± 0.1 101.6 ± 0.7 5.4 ± 0.2 104.6 ± 5.0 5.4 ± 0.1
Diabetic 62.9 ± 4.3a 3.4 ± 0.2 64.6 ± 3.0a 3.6 ± 0.2 64.5 ± 4.5a 3.5 ± 0.2 69.2 ± 6.2a 3.5 ± 0.2
Quercetin (diabetic) 83.4 ± 2.5b 4.8 ± 0.1 84.7 ± 2.2b 4.8 ± 0.1 79.3 ± 1.2ab 4.5 ± 0.2 81.2 ± 1.9ab 4.8 ± 0.2
Metformin (diabetic) 83.0 ± 1.4b 4.8 ± 0.1 87.2 ± 4.2b 5.2 ± 0.2 84.4 ± 4.7ab 4.6 ± 0.2 84.6 ± 2.1ab 4.8 ± 0.1
Quercetin + Metformin (diabetic) 96.8 ± 2.2bcd 5.0 ± 0.1 95.3 ± 3.8b 5.1 ± 0.1 93.8 ± 2.4b 5.1 ± 0.1 100.2 ± 2.6bcd 5.2 ± 0.1

Data represent mean ± SEM.

The alphabet, ‘a’ shows a significant difference in comparison with normal control (p < 0.05).

The alphabet, ‘b’ shows a significant difference in comparison to diabetic control (p < 0.05).

The alphabet, ‘c’ shows a significant difference in comparison with a quercetin treatment group (p < 0.05).

The alphabet, ‘d’ shows a significant difference in comparison with the metformin treatment group (p < 0.05).